S100P Human

S100 Calcium Binding Protein P Human Recombinant
Cat. No.
BT1814
Source
Escherichia Coli.
Synonyms
Protein S100-P, S100 calcium-binding protein P, S100P, S100E, MIG9.
Appearance
Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The Recombinant Human S100P has a molecular mass of 10.4 kDa containing 95 amino acid residues of the human S100P.

Product Specs

Introduction
S100P, initially identified as a 95-amino acid placental protein, exhibits approximately 50% sequence homology with S100 proteins alpha and beta found in the brain. S100 proteins are small, dimeric members of the EF-hand superfamily of Ca(2+)-binding proteins. These proteins are believed to be involved in intracellular Ca(2+) signaling by binding to and regulating target proteins in a Ca(2+)-dependent manner. Besides Ca2+, S100P also binds to Zn2+ and Mg2+. The gene encoding S100P is located on chromosome 4p16. Studies have shown S100P to be dysregulated in androgen-independent prostate cancer cell lines, including LNCaP-R, DU145, and PC3, suggesting a potential role in prostate cancer development. Overexpression of S100P is observed in ductal hyperplasias, in situ and invasive ductal carcinoma, but not in normal tissues. This overexpression is an early event that may contribute to the immortalization of human breast epithelial cells in vitro and tumor progression in vivo. In NIH3T3 cells, S100P expression resulted in the protein's presence in the culture medium, increased cellular proliferation, and enhanced survival after detachment from the culture substrate or exposure to the chemotherapeutic agent 5-fluorouracil. These effects of S100P expression were replicated by adding purified S100P to wild-type NIH3T3 cells in a time- and concentration-dependent manner, leading to the activation of Erks and NFκB. To investigate the mechanisms underlying these effects, researchers explored the hypothesis that S100P activates RAGE (Receptor for Activated Glycation End-Products). Results showed that S100P co-immunoprecipitated with RAGE. Moreover, agents that interfere with RAGE, such as an amphoterin-derived peptide known to antagonize RAGE activation, anti-RAGE antibodies, and the expression of a dominant-negative RAGE, blocked S100P's effects on cell signaling, proliferation, and survival. These findings indicate that S100P may act in an autocrine fashion via RAGE to stimulate cell proliferation and survival.
Description
Recombinant Human S100P is a protein with a molecular weight of 10.4 kDa, composed of 95 amino acid residues of the human S100P protein.
Physical Appearance
White powder, lyophilized and filtered.
Formulation
The protein solution is filtered through a 0.4 μm filter and then lyophilized from a 0.5 mg/ml solution in 0.05M Phosphate buffer with a pH of 7.2 and 0.1M NaCl.
Solubility
To reconstitute the lyophilized protein, add deionized water and allow the pellet to dissolve completely.
Stability
The lyophilized protein should be stored at -20°C. After reconstitution, aliquot the protein to prevent repeated freeze-thaw cycles. The reconstituted protein is stable at 4°C for a limited period and shows no significant change after two weeks at this temperature.
Purity
The purity of the protein is greater than 95% as determined by SDS-PAGE analysis.
Synonyms
Protein S100-P, S100 calcium-binding protein P, S100P, S100E, MIG9.
Source
Escherichia Coli.
Amino Acid Sequence
MTELEAAMGM IIDVFSRYSG SEGSTQTLTK GELKVLMEKE LPGFLQSGKD KDAVDKLLKD LDANGDAQVD FSEFIVFVAA ITSACHKYFE KAGLK.

Product Science Overview

Introduction

S100 Calcium Binding Protein P (S100P) is a member of the S100 family of proteins, which are known for their role in calcium-binding and signal transduction. These proteins are involved in various cellular processes, including cell cycle progression, differentiation, and metabolism .

Discovery and Structure

S100P was first isolated from human placenta and is composed of 95 amino acids . It contains two EF-hand calcium-binding motifs, which are characteristic of the S100 protein family . In addition to binding calcium ions (Ca²⁺), S100P can also bind zinc (Zn²⁺) and magnesium (Mg²⁺) ions .

Expression and Function

S100P is expressed in a variety of normal human tissues, including the placenta, esophagus, stomach, duodenum, large intestine, prostate, and leukocytes . At the protein level, the highest expression is observed in the placenta and stomach . S100P plays a role in calcium-dependent signal transduction pathways, contributing to the regulation of cell cycle, growth, differentiation, and metabolism .

Role in Cancer

S100P is overexpressed in several types of cancers, including breast, colon, prostate, pancreatic, and lung carcinomas . Its overexpression has been linked to carcinogenic processes, making it a potential tumor biomarker . For instance, in pancreatic cancer, S100P overexpression is due to hypomethylation of its gene . In prostate cancer, its expression is regulated by androgens and interleukin-6 . Additionally, retinoic acid has been reported to induce S100P expression in gastric cancer cell lines .

Clinical Implications

Given its widespread expression in both normal and malignant tissues, S100P represents a potential target for diagnostic and therapeutic applications . Its high expression in certain tumors suggests that it could be used as a biomarker for early detection and treatment of cancer .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.